Optical coherence tomography (OCT) is an emerging imaging modality that provides high-resolution, microstructural information on atherosclerotic plaques in biological systems. Intracoronary OCT can identify thin-cap fibroatheroma and other vulnerable plaques that may be responsible for acute coronary events. These characteristics make OCT helpful in guiding coronary management and interventions, including stent apposition and early identification of procedure-related complications. OCT is being assessed for its potential role in carotid plaque characterization and in the diagnosis of peripheral arterial atherosclerosis. Its current use in studying carotid and cerebral vasculature and in the diagnosis of peripheral arterial diseases is limited and ill defined, but it is finding increasing application in these areas. Its performance can be further improved by increasing the signal to noise ratio and by using dynamic focus tracking techniques. It can potentially be used to monitor the progression and regression of atherosclerosis in the coronary, cerebral and peripheral vasculature. New indications for its use in vascular medicine are emerging as its technology continues to improve over time.
1 Tearney GJ Brezinski ME Bouma BE . In vivo endoscopic optical biopsy with optical coherence tomography. Science1997; 276: 2037–2039.
2.
2 Brezinski ME Tearney GJ Bouma BE . Optical coherence tomography for optical biopsy. Properties and demonstration of vascular pathology. Circulation1996; 93: 1206–1213.
3.
3 Fujimoto JG Pitris C Boppart SA Brezinski ME . Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia2000; 2: 9–25.
4.
4 Huang D Swanson EA Lin CP . Optical coherence tomography. Science1991; 254: 1178–1181.
5.
5 Swanson EA . In vivo retinal imaging by optical coherence tomography. Optics Lett1993; 18: 1864–1866.
6.
6 Fujimoto JG . Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol2003; 21: 1361–1367.
7.
7 Fujimoto JG Brezinski ME Tearney GJ . Optical biopsy and imaging using optical coherence tomography. Nat Med1995; 1: 970–972.
8.
8 Brezinski ME Tearney GJ Weissman NJ . Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart1997; 77: 397–403.
9.
9 Pinto TL Waksman R . Clinical applications of optical coherence tomography. J Interv Cardiol2006; 19: 566–573.
10.
10 Welzel J Lankenau E Birngruber R Engelhardt R . Optical coherence tomography of the human skin. J Am Acad Dermatol1997; 37: 958–963.
11.
11 Li XD Boppart SA Van Dam J . Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett’s esophagus. Endoscopy2000; 32: 921–930.
12.
12 Tearney GJ Brezinski ME Boppart SA . Images in cardiovascular medicine. Catheter-based optical imaging of a human coronary artery. Circulation1996; 94: 3013.
13.
13 Prabhudesai V Phelan C Yang Y Wang RK Cowling MG . The potential role of optical coherence tomography in the evaluation of vulnerable carotid atheromatous plaques: a pilot study. Cardiovasc Intervent Radiol2006; 29: 1039–1045.
14.
14 Meissner OA Rieber J Babaryka G . Intravascular optical coherence tomography: comparison with histopathology in atherosclerotic peripheral artery specimens. J Vasc Interv Radiol2006; 17: 343–349.
15.
15 Satomura Y Seki J Ooi Y Yanagida T Seiyama A . In vivo imaging of the rat cerebral microvessels with optical coherence tomography. Clin Hemorheol Microcirc2004; 31: 31–40.
16.
16 Farb A Burke AP Tang AL . Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation1996; 93: 1354–1363.
17.
17 Naghavi M Libby P Falk E . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation2003; 108: 1664–1672.
18.
18 Kolodgie FD Virmani R Burke AP . Pathologic assessment of the vulnerable human coronary plaque. Heart2004; 90: 1385–1391.
19.
19 Libby P . Current concepts of the pathogenesis of the acute coronary syndromes. Circulation2001; 104: 365–372.
20.
20 Kolodgie FD Burke AP Farb A . The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol2001; 16: 285–292.
21.
21 Virmani R Kolodgie FD Burke AP Farb A Schwartz SM . Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol2000; 20: 1262–1275.
22.
22 Davies MJ . Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White lecture 1995. Circulation1996; 94: 2013–2020.
23.
23 Cheng GC Loree HM Kamm RD Fishbein MC Lee RT . Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation1993; 87: 1179–1187.
24.
24 Gossl M Versari D Hildebrandt H . Vulnerable plaque: detection and management. Med Clin North Am2007; 91: 573–601.
25.
25 Nissen SE Yock P . Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation2001; 103: 604–616.
26.
26 Vaina S Stefanadis C . Detection of the vulnerable coronary atheromatous plaque. Where are we now. Int J Cardiovasc Intervent2005; 7: 75–87.
27.
27 Rieber J Meissner O Babaryka G . Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coron Artery Dis2006; 17: 425–430.
28.
28 Ishibashi F Aziz K Abela GS Waxman S . Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. J Interv Cardiol2006; 19: 17–25.
29.
29 Tearney GJ Jang IK Bouma BE . Optical coherence tomography for imaging the vulnerable plaque. J Biomed Opt2006; 11: 021002.
30.
30 Yabushita H Bouma BE Houser SL . Characterization of human atherosclerosis by optical coherence tomography. Circulation2002; 106: 1640–1645.
31.
31 Shite J Matsumoto D Yokoyama M . Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J2006; 27: 1389.
32.
32 Gupta R Raffel OC Jang IK . Severe intimal hyperplasia after sirolimus eluting stent deployment: evaluation by optical coherence tomography. Heart2007; 93: 754.
33.
33 Tearney GJ Yabushita H Houser SL . Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation2003; 107: 113–119.
34.
34 Kume T; Akasaka T; Kawamoto T; . Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006; 152: 755.e1–4.
35.
35 Giattina SD Courtney BK Herz PR . Assessment of coronary plaque collagen with polarization sensitive optical coherence tomography (PS-OCT). Int J Cardiol2006; 107: 400–409.
36.
36 Chia S Christopher Raffel O Takano M Tearney GJ Bouma BE Jang IK . In-vivo comparison of coronary plaque characteristics using optical coherence tomography in women vs. men with acute coronary syndrome. Coron Artery Dis2007; 18: 423–427.
37.
37 Nadkarni SK Pierce MC Park BH . Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol2007; 49: 1474–1481.
38.
38 Jang IK Bouma BE Kang DH . Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol2002; 39: 604–609.
39.
39 Sawada T Shite J Garcia-Garcia HM . Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J2008; 29: 1136–1146.
40.
40 Diaz-Sandoval LJ Bouma BE Tearney GJ Jang IK . Optical coherence tomography as a tool for percutaneous coronary interventions. Catheter Cardiovasc Interv2005; 65: 492–496.
41.
41 Regar E Schaar J Serruys PW . Images in cardiology. Acute recoil in sirolimus eluting stent: real time, in vivo assessment with optical coherence tomography. Heart2006; 92: 123.
42.
42 Suzuki Y Ikeno F Yeung AC . Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. J Invasive Cardiol2006; 18: 111–114.
43.
43 Ito S Itoh M Suzuki T . Intracoronary imaging with optical coherence tomography after cutting balloon angioplasty for in-stent restenosis. J Invasive Cardiol2005; 17: 369–370.
44.
44 Kume T Akasaka T Kawamoto T . Visualization of neointima formation by optical coherence tomography. Int Heart J2005; 46: 1133–1136.
45.
45 Matsumoto D Shite J Shinke T . Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J2007; 28: 961–967.
46.
46 Yao ZH Matsubara T Inada T Suzuki Y Suzuki T . Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin Med J2008; 121: 503–507.
47.
47 AbuRahma AF Kyer PD Robinson PA Hannay RS . The correlation of ultrasonic carotid plaque morphology and carotid plaque hemorrhage: clinical implications. Surgery1998; 124: 721–726.
48.
48 Aburahma AF Thiele SP Wulu JT . Prospective controlled study of the natural history of asymptomatic 60% to 69% carotid stenosis according to ultrasonic plaque morphology. J Vasc Surg2002; 36: 437–442.
49.
49 Gronholdt ML Nordestgaard BG Schroeder TV Vorstrup S Sillesen H . Ultrasonic echolucent carotid plaques predict future strokes. Circulation2001; 104: 68–73.
50.
50 Schulte-Altedorneburg G Droste DW Haas N . Preoperative b-mode ultrasound plaque appearance compared with carotid endarterectomy specimen histology. Acta Neurol Scand2000; 101: 188–194.
51.
51 Eliasziw M Rankin RN Fox AJ Haynes RB Barnett HJ . Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) group. Stroke1995; 26: 1747–1752.
52.
52 Hatsukami TS Ross R Polissar NL Yuan C . Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation2000; 102: 959–964.
53.
53 Coombs BD Rapp JH Ursell PC Reilly LM Saloner D . Structure of plaque at carotid bifurcation: high-resolution MRI with histological correlation. Stroke2001; 32: 2516–2521.
54.
54 Yuan C Mitsumori LM Ferguson MS . In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation2001; 104: 2051–2056.
55.
55 Adame IM de Koning PJ Lelieveldt BP Wasserman BA Reiber JH van der Geest RJ . An integrated automated analysis method for quantifying vessel stenosis and plaque burden from carotid MRI images: combined postprocessing of MRA and vessel wall MR. Stroke2006; 37: 2162–2164.
56.
56 Kawahara I Morikawa M Honda M . High-resolution magnetic resonance imaging using gadolinium-based contrast agent for atherosclerotic carotid plaque. Surg Neurol2007; 68: 60–65.
57.
57 Cai J Hatsukami TS Ferguson MS . In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation2005; 112: 3437–3444.
58.
58 Howarth S Li ZY Trivedi RA . Correlation of macrophage location and plaque stress distribution using USPIO-enhanced MRI in a patient with symptomatic severe carotid stenosis: a new insight into risk stratification. Br J Neurosurg2007; 21: 396–398.
59.
59 Tang TY Howarth SP Li ZY . Correlation of carotid atheromatous plaque inflammation with biomechanical stress: utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis2008; 196: 879–887.
60.
60 Trivedi RA Mallawarachi C . U-King-Im, JM, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol2006; 26: 1601–1606.
61.
61 Gronholdt ML Wagner A Wiebe BM . Spiral computed tomographic imaging related to computerized ultrasonographic images of carotid plaque morphology and histology. J Ultrasound Med2001; 20: 451–458.
62.
62 Walker LJ Ismail A McMeekin W Lambert D Mendelow AD Birchall D . Computed tomography angiography for the evaluation of carotid atherosclerotic plaque: correlation with histopathology of endarterectomy specimens. Stroke2002; 33: 977–981.
63.
63 Zimarino M Prati F Stabile E . Optical coherence tomography accurately identifies intermediate atherosclerotic lesions – an in vivo evaluation in the rabbit carotid artery. Atherosclerosis2007; 193: 94–101.
64.
64 Divetia A Hsieh T Zhang J Chen Z Bachman M Li G . Dynamically focused optical coherence tomography for endoscopic applications. Appl Phys Lett2005; 86: 103902.
65.
65 Pircher M Gotzinger E Hitzenberger CK . Dynamic focus in optical coherence tomography for retinal imaging. J Biomed Opt2006; 11: 054013.
66.
66 Thorell WE Chow MM Prayson RA . Optical coherence tomography: a new method to assess aneurysm healing. J Neurosurg2005; 102: 348–354.
67.
67 Kawase Y Suzuki Y Ikeno F . Comparison of nonuniform rotational distortion between mechanical IVUS and OCT using a phantom model. Ultrasound Med Biol2007; 33: 67–73.
68.
68 Stamper D Weissman NJ Brezinski M . Plaque characterization with optical coherence tomography. J Am Coll Cardiol2006; 47: C69–C79.
69.
69 Brezinski M Saunders K Jesser C Li X Fujimoto J . Index matching to improve optical coherence tomography imaging through blood. Circulation2001; 103: 1999–2003.
70.
70 Van der Meer FJ Faber DJ Cilesiz I van Gemert MJ van Leeuwen TG . Temperature-dependent optical properties of individual vascular wall components measured by optical coherence tomography. J Biomed Opt2006; 11: 041120.
